The next step in the genomics revolution is to incorporate genomics into drug testing and development, says genomics pioneer J. Craig Venter. As genome sequencing has gotten faster and cheaper, it has also gotten less accurate, and a diploid genome map is necessary to pinpoint the genetics associated with a given disease, Venter said. His new institute on the University of California, San Diego, campus will focus on synthetic and environmental genomics research as well as the relationship between microbiomes and disease.

Related Summaries